Cytokinetics (NASDAQ:CYTK) will host a virtual Investor and Analyst Day on Wednesday, July 15, from 8:30 am – 11:30 am ET.
Panel discussions will address the changing landscape in heart failure therapy and emerging treatments for hypertrophic cardiomyopathy.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.